美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lunai Bioworks

1.25

-0.0500-3.85%

盤後：1.20-0.0485-3.88%19:44 EST

成交量：21.23萬

成交額：26.55萬

市值：2,928.83萬

市盈率：-0.17

高：1.29

開：1.28

低：1.20

收：1.30

52周最高：21.00

52周最低：0.8100

股本：2,343.07萬

流通股本：1,500.00萬

量比：0.40

換手率：1.42%

股息：- -

股息率：- -

每股收益(TTM):-7.2217

每股收益(LYR):-10.7843

淨資產收益率：-308.01%

總資產收益率：-14.85%

市淨率：-2.25

市盈率(LYR):-0.12

資料載入中...

總覽公司新聞資訊公告

Lunai Bioworks獲得首份許可意向書，標誌着在類人癌症模型中實現完全腫瘤退化的重大突破

Lunai Bioworks Inc.盤中異動早盤快速拉昇5.24%

Lunai Bioworks Inc.盤中異動大幅拉昇5.83%報1.090美元

Lunai Bioworks在臨牀前人源化模型中實現原發性和轉移性胰腺腫瘤的完全消退，標誌着異體癌症免疫療法的突破

Lunai Bioworks Inc.盤中異動早盤股價大跌5.83%報0.970美元

Lunai Bioworks實現同種異體癌症免疫療法的重大突破

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LNAI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":1.25,"timestamp":1764968400000,"preClose":1.3,"halted":0,"volume":212308,"hourTrading":{"tag":"盘后","latestPrice":1.2015,"preClose":1.25,"latestTime":"19:44 EST","volume":19661,"amount":23842.5812,"timestamp":1764981849874},"delay":0,"floatShares":15000000,"shares":23430653,"eps":-7.221734,"marketStatus":"休市中","change":-0.05,"latestTime":"12-05 16:00:00 EST","open":1.28,"high":1.2899,"low":1.2,"amount":265539.666378,"amplitude":0.069154,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.221734,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.2098,"preClose":1.3,"latestTime":"08:54 EST","volume":5519,"amount":6797.1545923,"timestamp":1764942899153},"postHourTrading":{"tag":"盘后","latestPrice":1.2015,"preClose":1.25,"latestTime":"19:44 EST","volume":19661,"amount":23842.5812,"timestamp":1764981849874},"volumeRatio":0.39743747654918254,"impliedVol":1.4337,"impliedVolPercentile":0.4667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":15000000,"roa":"-14.85%","roe":"-308.01%","lyrEps":-10.784282,"volumeRatio":0.39743747654918254,"shares":23430653,"dividePrice":0,"high":1.2899,"amplitude":0.069154,"preClose":1.3,"low":1.2,"week52Low":0.81,"pbRate":"-2.25","week52High":21,"institutionHeld":0,"latestPrice":1.25,"eps":-7.221734,"divideRate":0,"volume":212308,"delay":0,"ttmEps":-7.221734,"open":1.28,"prevYearClose":8.355,"prevWeekClose":1.18,"prevMonthClose":1.18,"prevQuarterClose":1.42,"fiveDayClose":1.18,"twentyDayClose":1.02,"sixtyDayClose":2.006},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"LNAI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-09-29","symbol":"LNAI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2025-05-15","symbol":"LNAI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-02-19","symbol":"LNAI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2025-12-05","current":-0.173089,"percent":0.066667,"low":-0.265446,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"high":-0.108594,"avg":-0.163761,"sd":0.041225,"marketCap":30462108},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497},{"date":"2025-11-21","current":-0.254829,"twenty":-0.163557,"median":-0.147149,"eighty":-0.123011,"marketCap":33376540},{"date":"2025-11-28","current":-0.211108,"twenty":-0.166054,"median":-0.152344,"eighty":-0.125001,"marketCap":27650221},{"date":"2025-12-05","current":-0.232577,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"marketCap":30462108}],"updateTime":1765110272013},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LNAI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158338920","title":"Lunai Bioworks獲得首份許可意向書，標誌着在類人癌症模型中實現完全腫瘤退化的重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1158338920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158338920?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 20:46","pubTimestamp":1764074773,"startTime":"0","endTime":"0","summary":"Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2586440790","title":"Lunai Bioworks Inc.盤中異動 早盤快速拉昇5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586440790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586440790?lang=zh_tw&edition=fundamental","pubTime":"2025-11-24 23:21","pubTimestamp":1763997661,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时21分，Lunai Bioworks Inc.股票出现波动，股价快速拉升5.24%。截至发稿，该股报1.31美元/股，成交量2.6719万股，换手率0.11%，振幅6.66%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为633.82%、457.55%、69.59%，振幅较大的相关个股有Enlivex Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Pasithea Therapeutics Corp.，振幅分别为47.95%、42.12%、39.27%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","BK4139","RENB"],"gpt_icon":0},{"id":"2584599028","title":"Lunai Bioworks Inc.盤中異動 大幅拉昇5.83%報1.090美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584599028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584599028?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 23:31","pubTimestamp":1763479868,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日23时31分，Lunai Bioworks Inc.股票出现波动，股价大幅上涨5.83%。截至发稿，该股报1.090美元/股，成交量3.1332万股，换手率0.14%，振幅9.71%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为1740.14%、1017.54%、339.02%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、49.55%、44.48%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118233108950c7a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118233108950c7a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","BK4139","LNAI"],"gpt_icon":0},{"id":"1197356752","title":"Lunai Bioworks在臨牀前人源化模型中實現原發性和轉移性胰腺腫瘤的完全消退，標誌着異體癌症免疫療法的突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1197356752","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197356752?lang=zh_tw&edition=fundamental","pubTime":"2025-11-15 23:38","pubTimestamp":1763221107,"startTime":"0","endTime":"0","summary":"Lunai Bioworks在临床前人源化模型中实现原发性和转移性胰腺肿瘤的完全消退，标志着异体癌症免疫疗法的突破","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2583507637","title":"Lunai Bioworks Inc.盤中異動 早盤股價大跌5.83%報0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583507637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583507637?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 22:43","pubTimestamp":1763131397,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时43分，Lunai Bioworks Inc.股票出现异动，股价快速下跌5.83%。截至发稿，该股报0.970美元/股，成交量3.6453万股，换手率0.16%，振幅8.74%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aspire Biopharma Holdings, Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为748.98%、80.30%、45.24%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cypherpunk Technologies Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为46.41%、28.97%、26.50%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142243189504b557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142243189504b557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","BK4139","RENB"],"gpt_icon":0},{"id":"2581401047","title":"Lunai Bioworks實現同種異體癌症免疫療法的重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2581401047","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581401047?lang=zh_tw&edition=fundamental","pubTime":"2025-11-07 07:56","pubTimestamp":1762473360,"startTime":"0","endTime":"0","summary":"Lunai Bioworks在临床前人源化模型中实现原发及转移性胰腺肿瘤完全消退，标志着同种异体癌症免疫疗法的重大突破 Lunai Bioworks宣布其第二代同种异体树突状细胞疗法平台研究成果已发表于《Vaccines》期刊。尽管该同种异体DC产品已在胰腺癌模型中得到验证，但其治疗潜力有望拓展至多种实体瘤。关于LunaiLunai Bioworks Inc.是一家由AI驱动的药物发现与生物防御公司，致力于开拓安全且负责任的生成式生物学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4817230_ZH17230_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LNAI","BK4139","RENB"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}